Due to the heterogeneous nature of immune cells in the tumor microenvironment, in addition to tumor-killing cells (e.g., CD8+ T cells), there are also immune cells (e.g., T regulatory cells) that can help tumors escape from immune surveillance. The gene discussed is CD8A; the disease is neoplasm.